Invention Grant
- Patent Title: Pharmaceutical compositions containing clofazimine for inhibiting Clostridium difficile activity
-
Application No.: US15831237Application Date: 2017-12-04
-
Publication No.: US10064860B2Publication Date: 2018-09-04
- Inventor: Venkata M. Reddy , Wolf Prensky , Sharanjit VedBrat
- Applicant: KamTek, Inc.
- Applicant Address: US MD Frederick
- Assignee: KamTek, Inc.
- Current Assignee: KamTek, Inc.
- Current Assignee Address: US MD Frederick
- Agency: Wiley Rein LLP
- Main IPC: A61K31/498
- IPC: A61K31/498 ; C07D241/46 ; A61K31/7048 ; A61K38/14 ; A61K31/4164 ; A61K9/00
Abstract:
Methods for inhibiting the activity of Clostridium difficile in a subject comprises administering to the subject a pharmaceutical composition consisting of clofazimine and at least one pharmaceutically acceptable excipient. Pharmaceutical compositions consisting of clofazimine at least one pharmaceutically acceptable excipient are provided for treating Clostridium difficile infection and diseases or symptoms associated therewith.
Public/Granted literature
- US20180092914A1 SYNERGISTIC CLOFAZIMINE/METRONIDAZOLE COMBINATION FOR TREATING CLOSTRIDIUM DIFFICILE Public/Granted day:2018-04-05
Information query
IPC分类:
